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background:  Coronary CT Angiography (CTCA) has high sensitivity to exclude coronary artery disease (CAD), but recent large trials compared 
mainly to SPECT. Whether CTCA has advantages over exercise treadmill ECG (ExECG) is unclear.
methods: Randomized, prospective, single-center study in a large academic Australian hospital ER. From March 2010 to April 2011, total 562 
subjects with low-intermediate risk chest pain were randomized after the first negative serum troponin to either dual-source CTCA (n=322) or ExECG 
(n=240). Two cardiologists adjudicated ACS using available data including 30day follow up. Primary outcomes were diagnostic accuracy, length of 
stay, cost-utility
results: ExECG arm had 214 negative and 27 positive studies, 22 of which were false-positive and one false-negative. CTCA arm had 287 negative 
studies [195 with <50% stenosis and 93 with no disease] and 35 positive studies. Diagnostic accuracy see Table. Length of stay was significantly 
reduced by CTCA [13.5 hours (95%CI 11.2-15.7)] compared ExECG [19.7 hours (95%CI 17.4-22.1), p<0.0005]. Per-patient cost-utility was 
significantly lower by CTCA [$2193 vs $2704, P<0.001]
Conclusions: CT-COMPARE, the largest prospective, randomized trial of CTCA compared to treadmill ECG, showed similarly negative predictive value 
but higher sensitivity and positive predictive value. CTCA provides rapid discharge at surprisingly less expense than ExECG. This suggests CTCA should 
be considered first line in low-intermediate ER chest pain.
 
Diagnostic Accuracy of ExECG and CTCA arms
Arm SENS SPEC PPV NPV ROC-AUC
ExECG 83.3 90.6 18.5 99.5 0.87
CTCA>50% 100 94.4 51.4 100 0.97
CTCA>70% 94.4 99.3 89.5 99.7 0.97
